JHSM
Journal of Health Sciences and Medicine

Journal of Health Sciences and Medicine (JHSM) is an unbiased, peer-reviewed, and open access international medical journal. The Journal publishes interesting clinical and experimental research conducted in all fields of medicine, interesting case reports, and clinical images, invited reviews, editorials, letters, comments, and related knowledge.

ISSN: Active
eISSN: 2636-8579
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Submit Manuscript

Index
Original Article
R-Spondin1 and tumor necrosis factor-alpha in infertile women with polycystic ovary syndrome: relationships with insulin resistance and other parameters
Abstract
Aims: To evaluate the relationship between R-spondin1 (RSPO1) and Tumor Necrosis Factor-Alpha (TNF-?) levels with insulin resistance (IR) and other parameters in infertile women with polycystic ovary syndrome (PCOS). Material and
Methods: This case-control prospective observational study was carried out on 84 patients admitted to the University of Health Sciences Etlik Zübeyde Hanım Training and Research Hospital Gynecology and IVF Clinic and Medistate Hospital Gynecology and IVF Clinic between September 2020 and June 2021. Women aged 18-36 years diagnosed with infertility and PCOS constituted the PCOS group. Women who were diagnosed with infertility but not PCOS formed the control group. Cases were divided according to their body mass index (BMI) values into obese (BMI?25) and non-obese (BMI<25) groups.
Results: The mean age of the study group was 26.9±5.37 years. RSPO1 and TNF-? levels were higher in PCOS patients (p<0.001). Hip circumference (HC) was found to be higher in those with a diagnosis of PCOS (p<0.001). The group with the highest waist-to-hip ratio (WHR) was the obese-PCOS group (p<0.001). Glucose, insulin, and homeostatic model assessment for IR (HOMA-IR) levels were the highest in the obese-PCOS group (p<0.001). A positive correlation was found between RSPO1 and TNF-? (r=0.944, p<0.001). There was a positive correlation between the hip circumference and RSPO1 (r=0.255, p=0.0019) and TNF-? (r=0. 0.278, p=0.011). There were positive correlations between blood glucose and RSPO1 (r=0.343, p=0.001) and TNF-? levels (r=0.312, p=0.004) and between insulin and RSPO1 (r value=0.577, p<0.001) and TNF-? levels (r=0.569, p<0.001). HOMA-IR values were also found to correlate with RSPO-1 and TNF-? levels (r= 0.619 and 0.608, p<0.001).
Conclusion: It can be concluded that RSPO1 and TNF-? levels may guide the assessment and management of IR and diabetes risk in infertile women with PCOS.

Keywords : Polycystic ovary syndrome, R-Spondin1, tumor necrosis factor-alpha, obesity, insulin resistance

Download Article


1. Zegers-Hochschild F, Adamson GD, Dyer S, et al. The internationalglossary on infertility and fertility care, 2017. Hum Reprod 2017;32: 1786-801.
2. Alanya Tosun Ş, Gurbuz T, Cebi A, Tosun A, Gokmen O, Usta M.Association of increased levels of omentin-1 and carotid intima-media thickness with early signs of cardiovascular risk in patientswith polycystic ovary syndrome: A prospective case control study.J Obstet Gynaecol Res 2022; 48: 169-77.
3. Gurbuz T, Alanya Tosun S, Cebi A, Gokmen O, Usta M.Investigating fetuin-A and paraoxonase-1 activity as markersin polycystic ovary syndrome based on body mass ındex: aprospective case-control study. Cureus 2021; 13: e18553.
4. G&uuml;rb&uuml;z T, Dokuzeyl&uuml;l G&uuml;ng&ouml;r N. Understanding the effectsof obesity over polycystic ovary syndrome by analyzing insulinresistance and thyroid hormone in different BMI levels. UlutaşMed J 2021; 7: 8-12.
5. Crosignani PG, Colombo M, Vegetti W, Somigliana E, GessatiA, Ragni G. Overweight and obese anovulatory patients withpolycystic ovaries: parallel improvements in anthropometricindices, ovarian physiology and fertility rate induced by diet.Hum Reprod 2003; 18: 1928-32.
6. Deugarte CM, Bartolucci AA, Azziz R. Prevalence of IR inthe polycystic ovary syndrome using the homeostasis modelassessment. Fertil Steril 2005; 83: 1454-60.
7. Glinka A, Dolde C, Kirsch N, et al. LGR4 and LGR5 are R-spondinreceptors mediating Wnt/&beta;-catenin and Wnt/PCP signalling.EMBO Rep 2011; 12: 1055-61.
8. De Lau WB, Snel B, Clevers HC. The R-spondin protein family.Genome Biol 2012; 13: 1-10.
9. Carmon KS, Gong X, Lin Q, Thomas A, Liu Q. R-spondinsfunction as ligands of the orphan receptors LGR4 and LGR5 toregulate Wnt/beta-catenin signaling. Proc Natl Acad Sci USA2011; 108: 11452-7.
10. Kang YE, Kim JM, Yi HS, et al. Serum R-Spondin 1 is a newsurrogate marker for obesity and insulin resistance. DiabetesMetab J 2019; 43: 368-376.
11. Pan H, Cui H, Liu S, et al.. Lgr4 gene regulates corpus luteummaturation through modulation of the WNT-mediated EGFR-ERK signaling pathway. Endocrinology. 2014; 155: 3624-3637.
12. Balchak SK, Marcinkiewicz JL. Evidence for the presence of tumornecrosis factor alpha receptors during ovarian development in therat. Biol Reprod 1999; 61: 1506-12.
13. Rotterdam ESHRE/ASRM-Sponsored PCOS ConsensusWorkshop Group. Revised 2003 consensus on diagnostic criteriaand long-term health risks related to polycystic ovary syndrome.Fertil Steril 2004; 81: 19-25.
14. Delitala AP, Capobianco G, Delitala G, Cherchi PL, DessoleS. Polycystic ovary syndrome, adipose tissue and metabolicsyndrome. Arch Gynecol Obstet 2017; 296: 405-19.
15. Kyrou I, Weickert MO, Randeva HS. Diagnosis and managementof polycystic ovary syndrome (PCOS). In Ajjan R, Orme SM,editors, Endocrinology and diabetes: case studies, questions andcommentaries. London (UK): Springer 2015; 99-113.
16. Kyrou I, Randeva HS, Tsigos C, Kaltsas G, Weickert MO. ClinicalProblems Caused by Obesity. 2018 Jan 11. In: Feingold KR,Anawalt B, Boyce A, et al. editors. Endotext [Internet]. SouthDartmouth (MA): MDText.com, Inc.; 2000-. PMID: 25905207.
17. Jin YR, Yoon JK. The R-spondin family of proteins: emergingregulators of WNT signaling. Int J Biochem Cell Biol 2012; 44:2278-87.
18. Kuchenbaecker KB, Ramus SJ, Tyrer J, et al. Identification of sixnew susceptibility loci for invasive epithelial ovarian cancer. NatGenet 2015; 47: 164-71.
19. Tomaselli S, Megiorni F, Lin L, et al. Human RSPO1/R-spondin1is expressed during early ovary development and augments&beta;-catenin signaling. PLoS One 2011; 6: e16366.
20. Chassot AA, Ranc F, Gregoire EP, et al. Activation of beta-cateninsignaling by Rspo1 controls differentiation of the mammalianovary. Hum Mol Genet 2008; 17: 1264-77.
21. Liu Q, Zhao Y, Xing H, et al. The role of R-spondin 1 throughactivating Wnt/&beta;-catenin in the growth, survival and migration ofovarian cancer cells. Gene 2019; 689: 124-30.
22. Wang J, Liu R, Wang F, et al. Ablation of LGR4 promotes energyexpenditure by driving white-to-brown fat switch. Nat Cell Biol2013; 15: 1455-63.
23. Wong VS, Yeung A, Schultz W, Brubaker PL. R-spondin-1 isa novel beta-cell growth factor and insulin secretagogue. J BiolChem 2010; 285: 21292-302.
24. Vgontzas AN, Bixler E, Chrousos G. Metabolic disturbances inobesity versus sleep apnoea: the importance of visceral obesityand insulin resistance. J Intern Med 2003; 254: 32-44.
25. Sayin NC, G&uuml;cer F, Balkanli-Kaplan P, et al. Elevated serumTNF-&alpha; levels in normal-weight women with polycystic ovaries orthe polycystic ovary syndrome. J Reprod Med 2003; 48: 165-70.
26. Olszanecka-Glinianowicz M, Banas M, Zahorska-Markiewicz B,et al. Is the polycystic ovary syndrome associated with chronicinflammation per se? Eur J Obstet Gynecol Reprod Biol 2007; 133:197-202.
27. Toulis KA, Goulis DG, Mintziori G, et al. Meta-analysis ofcardiovascular disease risk markers in women with polycysticovary syndrome. Hum Reprod Update. 2011; 17: 741-60.
28. Escobar-Morreale HF, Luque-Ram&iacute;rez M, Gonz&aacute;lez F. Circulatinginflammatory markers in polycystic ovary syndrome: a systematicreview and meta-analysis. Fertil Steril 2011; 95: 1048-58.
29. Hotamisligil GS, Budavari A, Murray D, et al. Reduced tyrosinekinase activity of the insulin receptor in obesity-diabetes. Centralrole of tumor necrosis factor-alpha. J Clin Invest 1994; 94: 1543-9.
30. Araya AV, Aguirre A, Romero C, Miranda C, Molina MC, FerreiraA. Evaluation of tumor necrosis factor alpha production in ex vivoshort term cultured whole blood from women with polycysticovary syndrome. Eur Cytokine Netw 2002; 13: 419-24.
31. Gao L, Gu Y, Yin X. High serum tumor necrosis factor-alphalevels in women with polycystic ovary syndrome: a meta-analysis.PLoS One 2016; 11: e0164021.
32. Kr&ouml;nke G, Uderhardt S, Kim KA, et al. R-spondin 1 protectsagainst inflammatory bone damage during murine arthritis bymodulating the Wnt pathway. Arthritis Rheum 2010; 62: 2303-12.
33. Choi BY, Chang SH, Cho HJ, et al. The association of radiographicprogression with serum R-spondin 1 (RSPO1) levels or Dickkopf-1(DKK1)/RSPO1 ratios in rheumatoid arthritis patients: clinicalevidence for reciprocal inhibition between DKK1 and RSPO1.Scand J Rheumatol 2014; 43: 453-61.
Article available in :
Volume 6, Issue 2, 2023
Page : 449-455
https://doi.org/10.32322/jhsm.1210721
Article Information
Received : 27 Kas 2022
Accepted : 19 Şub 2023
Published : 27 Mar 2023
Corresponding Author :

Tuğba Gürbüz: Department of Gynecology and Obstetric Clinic, Medistate Hospital, İstanbul, Turkiye

[email protected]
Citation : Gürbüz T, Gökmen O, Ayar Madenli A, Dilbaz B. R-Spondin1 and tumor necrosis factor-alpha in infertile women with polycystic ovary syndrome: relationships with insulin resistance and other parameters. J Health Sci Med 2023; 6(2): 449-455.

Read: 168
Cited: 0
Download : 162
_Footer